Virtus Investment Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,867
| Closed | -$109K | – | 389 |
|
|
2023
Q4 | $109K | Hold |
20,867
| – | – | 0.08% | 239 |
|
|
2023
Q3 | $329K | Sell |
20,867
-998
| -5% | -$15.7K | 0.22% | 116 |
|
|
2023
Q2 | $425K | Buy |
21,865
+14,557
| +199% | +$283K | 0.29% | 102 |
|
|
2023
Q1 | $207K | Sell |
7,308
-144
| -2% | -$4.09K | 0.15% | 179 |
|
|
2022
Q4 | $218K | Hold |
7,452
| – | – | 0.15% | 184 |
|
|
2022
Q3 | $197K | Buy |
+7,452
| New | +$197K | 0.09% | 199 |
|